Literature DB >> 35093094

Co-prevalence of human Papillomaviruses (HPV) and Epstein-Barr virus (EBV) in healthy blood donors from diverse nationalities in Qatar.

Ishita Gupta1, Gheyath K Nasrallah2, Anju Sharma1, Ayesha Jabeen1, Maria K Smatti2, Hamda A Al-Thawadi1, Ali A Sultan3, Moussa Alkhalaf4, Semir Vranic5, Ala-Eddin Al Moustafa6,7.   

Abstract

BACKGROUND: Infections by both human oncoviruses, human Papillomaviruses (HPV) and Epstein-Barr virus (EBV) are very common in the adult human population and are associated with various malignancies. While HPV is generally transmitted sexually or via skin-to-skin contact, EBV is frequently transmitted by oral secretions, blood transfusions and organ transplants. This study aims to determine the prevalence and circulating genotypes of HPV and EBV in healthy blood donors in Qatar.
METHODS: We explored the co-prevalence of high-risk HPVs and EBV in 378 males and only 7 females blood donors of different nationalities (mainly from Qatar, Egypt, Syria, Jordan, Pakistan, and India) residing in Qatar, using polymerase chain reaction (PCR). DNA was extracted from the buffy coat and genotyping was performed using PCR and nested-PCR targeting E6 and E7 as well as LMP-1 of HPV and EBV, respectively.
RESULTS: We found that from the total number of 385 cases of healthy blood donors studied, 54.8% and 61% of the samples are HPVs and EBV positive, respectively. Additionally, our data revealed that the co-presence of both high-risk HPVs and EBV is 40.4% of the total samples. More significantly, this study pointed out for the first time that the most frequent high-risk HPV types in Qatar are 59 (54.8%), 31 (53.7%), 52 (49.1%), 51 (48.6%), 58 (47%) and 35 (45.5%), while the most commonly expressed low-risk HPV types are 53 (50.6%), 11 (45.5), 73 (41.7%) and 6 (41.3%), with all the cases showing multiple HPVs infection.
CONCLUSION: In this study, we demonstrated for the first time that HPV and EBV are commonly co-present in healthy blood donors in Qatar. On the other hand, it is important to highlight that these oncoviruses can also be co-present in several types of human cancers where they can cooperate in the initiation and/or progression of these cancers. Therefore, more studies regarding the co-presence of these oncoviruses and their interaction are necessary to understand their cooperative role in human diseases.
© 2020. The Author(s).

Entities:  

Keywords:  EBV; HPV; Healthy blood donors; Qatar

Year:  2020        PMID: 35093094     DOI: 10.1186/s12935-020-01190-2

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  52 in total

Review 1.  The epithelial-mesenchymal transition (EMT) is regulated by oncoviruses in cancer.

Authors:  Xue Chen; Ann M Bode; Zigang Dong; Ya Cao
Journal:  FASEB J       Date:  2016-06-08       Impact factor: 5.191

2.  E5 and E6/E7 of high-risk HPVs cooperate to enhance cancer progression through EMT initiation.

Authors:  Ala-Eddin Al Moustafa
Journal:  Cell Adh Migr       Date:  2015-07-15       Impact factor: 3.405

Review 3.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

4.  Natural history of genital warts.

Authors:  J D Oriel
Journal:  Br J Vener Dis       Date:  1971-02

5.  Could human papillomaviruses be spread through blood?

Authors:  Sohrab Bodaghi; Lauren V Wood; Gregg Roby; Celia Ryder; Seth M Steinberg; Zhi-Ming Zheng
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

6.  An association between human papillomavirus 16/18 deoxyribonucleic acid in peripheral blood with p16 protein expression in neoplastic cervical lesions.

Authors:  Horng-Jyh Tsai; Ya-Wen Peng; Long-Yau Lin; Ming-Chih Chou; Huei Lee; Hui-Ling Chiou
Journal:  Cancer Detect Prev       Date:  2005-11-09

7.  Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis.

Authors:  C J Tseng; C C Pao; J D Lin; Y K Soong; J H Hong; S Hsueh
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

8.  Epstein-Barr virus latent antigens EBNA3C and EBNA1 modulate epithelial to mesenchymal transition of cancer cells associated with tumor metastasis.

Authors:  Nivedita Gaur; Jaya Gandhi; Erle S Robertson; Subhash C Verma; Rajeev Kaul
Journal:  Tumour Biol       Date:  2014-12-13

Review 9.  Genital human papillomavirus infections: current and prospective therapies.

Authors:  Margaret A Stanley
Journal:  J Gen Virol       Date:  2012-02-08       Impact factor: 3.891

Review 10.  Classification of papillomaviruses.

Authors:  Ethel-Michele de Villiers; Claude Fauquet; Thomas R Broker; Hans-Ulrich Bernard; Harald zur Hausen
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.